Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) FCF Margin (2023 - 2025)

Historic FCF Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 904.07%.

  • Tonix Pharmaceuticals Holding's FCF Margin fell 2375200.0% to 904.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 741.06%, marking a year-over-year decrease of 1282700.0%. This contributed to the annual value of 604.77% for FY2024, which is 8099900.0% up from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's FCF Margin is 904.07%, which was down 2375200.0% from 768.77% recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's FCF Margin peaked at 449.23% during Q2 2024, and registered a low of 904.07% during Q3 2025.
  • Moreover, its 3-year median value for FCF Margin was 674.67% (2024), whereas its average is 669.64%.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 2621700bps in 2024, then crashed by -3195400bps in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's FCF Margin stood at 602.75% in 2023, then increased by 6bps to 566.73% in 2024, then crashed by -60bps to 904.07% in 2025.
  • Its last three reported values are 904.07% in Q3 2025, 768.77% for Q2 2025, and 682.79% during Q1 2025.